[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @PhilipHemme Philip Hemme Philip Hemme posts on X about $bntx, $argx, $gmab, $asnd the most. They currently have XXXXX followers and XXX posts still getting attention that total XX engagements in the last XX hours. ### Engagements: XX [#](/creator/twitter::971525090/interactions)  - X Week XXXXX -XX% - X Month XXXXXX +263% - X Months XXXXXX +189% - X Year XXXXXX +494% ### Mentions: X [#](/creator/twitter::971525090/posts_active)  - X Week XX -XXXX% - X Month XX +7.70% - X Months XX +279% - X Year XX +61% ### Followers: XXXXX [#](/creator/twitter::971525090/followers)  - X Week XXXXX +0.03% - X Month XXXXX +0.06% - X Months XXXXX +1.80% - X Year XXXXX -XXXX% ### CreatorRank: undefined [#](/creator/twitter::971525090/influencer_rank)  ### Social Influence [#](/creator/twitter::971525090/influence) --- **Social category influence** [finance](/list/finance) [cryptocurrencies](/list/cryptocurrencies) [stocks](/list/stocks) **Social topic influence** [$bntx](/topic/$bntx) #6, [$argx](/topic/$argx) #9, [$gmab](/topic/$gmab) #15, [$asnd](/topic/$asnd) #6, [$sobi](/topic/$sobi) #1, [$abvx](/topic/$abvx) #19, [$mrus](/topic/$mrus) #10, [$zeal](/topic/$zeal) #5, [$camrf](/topic/$camrf) #1, [$mltx](/topic/$mltx) #5 **Top accounts mentioned or mentioned by** [@drrichjlaw](/creator/undefined) [@lifescivc](/creator/undefined) [@evotec](/creator/undefined) [@bernatolle](/creator/undefined) [@bertrandbio](/creator/undefined) [@adaptimmune](/creator/undefined) [@peterkolchinsky](/creator/undefined) [@angelosgeo](/creator/undefined) [@vedantabio](/creator/undefined) [@abfredriksen](/creator/undefined) [@cangermayer](/creator/undefined) [@grok](/creator/undefined) [@livemunro](/creator/undefined) [@robotaxi](/creator/undefined) [@yaireinhorn](/creator/undefined) [@wsj](/creator/undefined) [@leonelissen](/creator/undefined) [@unusualwhales](/creator/undefined) [@vonderleyen](/creator/undefined) [@epbresearch](/creator/undefined) **Top assets mentioned** [Merus N.V. Common Shares (MRUS)](/topic/$mrus) [MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX)](/topic/$mltx) [Baklava (BAVA)](/topic/$bava) [Summit Therapeutics Inc. Common Stock (SMMT)](/topic/$smmt) [Bitcoin Incognito (XBI)](/topic/$xbi) [Morgan Stanley (MS)](/topic/morgan-stanley) [Nano (XNO)](/topic/$nano) ### Top Social Posts [#](/creator/twitter::971525090/posts) --- Top posts by engagements in the last XX hours "Big private takeover for $BAVA" [X Link](https://x.com/PhilipHemme/status/1950001197206700160) [@PhilipHemme](/creator/x/PhilipHemme) 2025-07-29T01:11Z 6262 followers, XXX engagements "NEWS: BioNTech ( $BNTX) just unveiled positive interim Ph2 results for its PD-L1VEGF bispecific. A potential blockbuster and strong challenger to Summit ( $SMMT) & 3SBio 👀" [X Link](https://x.com/PhilipHemme/status/1965264443761426461) [@PhilipHemme](/creator/x/PhilipHemme) 2025-09-09T04:02Z 6262 followers, 1807 engagements "Who are the biggest biotechs in Europe 🤩 Want access to the data 👉 Want full access to the data in a digital web appwith list view market caps pipelines and therapeutic areas Comment Map and Ill send it to you rapidly 💬 Top 10: $ARGX $BNTX $GMAB $ASND $SOBI $ABVX $MRUS $ZEAL $CAMRF $MLTX" [X Link](https://x.com/PhilipHemme/status/1967499229791654311) [@PhilipHemme](/creator/x/PhilipHemme) 2025-09-15T08:02Z 6262 followers, 2003 engagements "Which biotech didn't you know 🤔 Top 10: $ARGX $BNTX $GMAB $ASND $SOBI $ABVX $MRUS $ZEAL $CAMRF $MLTX. $XBI" [X Link](https://x.com/PhilipHemme/status/1967871843601457518) [@PhilipHemme](/creator/x/PhilipHemme) 2025-09-16T08:43Z 6262 followers, 43.2K engagements "What The acquisition centers on bispecific petosemtamab Merus breakthrough head and neck cancer drug with two FDA Breakthrough Therapy Designations and potential $1+ billion annual sales by 2029. Genmab will pay XX% premium funded through cash and $XXX billion in debt financing from Morgan Stanley. Why it matters The deal gives Genmab four proprietary programs expected to drive multiple new drug launches by 2027 and accelerates its transformation into a fully integrated biotechnology leader. Context: This is the largest acquisition in Genmabs history following the acquisition of ProfoundBio" [X Link](https://x.com/PhilipHemme/status/1972625890933698915) [@PhilipHemme](/creator/x/PhilipHemme) 2025-09-29T11:33Z 6263 followers, XXX engagements "EPISODE: Raising a $60M Series C in 2025 is tough. Daniela just did it to bring a breakthrough tissue therapeutic to the market The funding round is a testament to the fact that when there is a good product with good science and a clear unmet need.it is possible to find the right investors said CEO and co-founder Daniela Marino. She explains how @Cutiss_AG is building a decentralised production model for its tissue therapeutic that could replace skin grafts for severe burns. You can be as close as you can to the largest hospitals and try to serve the patients in a quicker and cheaper way. She" [X Link](https://x.com/PhilipHemme/status/1978007872555622429) [@PhilipHemme](/creator/x/PhilipHemme) 2025-10-14T08:00Z 6263 followers, XXX engagements "Friday night recording with Laurent from Nanobiotix now a billion-dollar biotech $NBTX $NANO" [X Link](https://x.com/PhilipHemme/status/1979221499887210789) [@PhilipHemme](/creator/x/PhilipHemme) 2025-10-17T16:22Z 6263 followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Philip Hemme posts on X about $bntx, $argx, $gmab, $asnd the most. They currently have XXXXX followers and XXX posts still getting attention that total XX engagements in the last XX hours.
Social category influence finance cryptocurrencies stocks
Social topic influence $bntx #6, $argx #9, $gmab #15, $asnd #6, $sobi #1, $abvx #19, $mrus #10, $zeal #5, $camrf #1, $mltx #5
Top accounts mentioned or mentioned by @drrichjlaw @lifescivc @evotec @bernatolle @bertrandbio @adaptimmune @peterkolchinsky @angelosgeo @vedantabio @abfredriksen @cangermayer @grok @livemunro @robotaxi @yaireinhorn @wsj @leonelissen @unusualwhales @vonderleyen @epbresearch
Top assets mentioned Merus N.V. Common Shares (MRUS) MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) Baklava (BAVA) Summit Therapeutics Inc. Common Stock (SMMT) Bitcoin Incognito (XBI) Morgan Stanley (MS) Nano (XNO)
Top posts by engagements in the last XX hours
"Big private takeover for $BAVA"
X Link @PhilipHemme 2025-07-29T01:11Z 6262 followers, XXX engagements
"NEWS: BioNTech ( $BNTX) just unveiled positive interim Ph2 results for its PD-L1VEGF bispecific. A potential blockbuster and strong challenger to Summit ( $SMMT) & 3SBio 👀"
X Link @PhilipHemme 2025-09-09T04:02Z 6262 followers, 1807 engagements
"Who are the biggest biotechs in Europe 🤩 Want access to the data 👉 Want full access to the data in a digital web appwith list view market caps pipelines and therapeutic areas Comment Map and Ill send it to you rapidly 💬 Top 10: $ARGX $BNTX $GMAB $ASND $SOBI $ABVX $MRUS $ZEAL $CAMRF $MLTX"
X Link @PhilipHemme 2025-09-15T08:02Z 6262 followers, 2003 engagements
"Which biotech didn't you know 🤔 Top 10: $ARGX $BNTX $GMAB $ASND $SOBI $ABVX $MRUS $ZEAL $CAMRF $MLTX. $XBI"
X Link @PhilipHemme 2025-09-16T08:43Z 6262 followers, 43.2K engagements
"What The acquisition centers on bispecific petosemtamab Merus breakthrough head and neck cancer drug with two FDA Breakthrough Therapy Designations and potential $1+ billion annual sales by 2029. Genmab will pay XX% premium funded through cash and $XXX billion in debt financing from Morgan Stanley. Why it matters The deal gives Genmab four proprietary programs expected to drive multiple new drug launches by 2027 and accelerates its transformation into a fully integrated biotechnology leader. Context: This is the largest acquisition in Genmabs history following the acquisition of ProfoundBio"
X Link @PhilipHemme 2025-09-29T11:33Z 6263 followers, XXX engagements
"EPISODE: Raising a $60M Series C in 2025 is tough. Daniela just did it to bring a breakthrough tissue therapeutic to the market The funding round is a testament to the fact that when there is a good product with good science and a clear unmet need.it is possible to find the right investors said CEO and co-founder Daniela Marino. She explains how @Cutiss_AG is building a decentralised production model for its tissue therapeutic that could replace skin grafts for severe burns. You can be as close as you can to the largest hospitals and try to serve the patients in a quicker and cheaper way. She"
X Link @PhilipHemme 2025-10-14T08:00Z 6263 followers, XXX engagements
"Friday night recording with Laurent from Nanobiotix now a billion-dollar biotech $NBTX $NANO"
X Link @PhilipHemme 2025-10-17T16:22Z 6263 followers, XXX engagements
/creator/x::PhilipHemme